| Variables | Final BCVA <20/200, n (%) | Final BCVA ≥20/200, n (%) | Or (95% CI)a | P valueb |
| Age (by year) | 48.00 ± 12.86 | 37.29 ± 15.90 | 1.055 (1.004, 1.108)c | 0.035d |
| Sex | | | | 1.000 | Male | 24 | 12 | 1.000 (0.160, 6.255) | | Female | 4 | 2 | 1 | |
| Occupation | | | | 0.225 | Farmer | 11 | 2 | 1 | | Worker | 14 | 9 | 0.283 (0.050, 1.585) | 0.259 | Others | 3 | 3 | 0.182 (0.020, 1.638) | 0.262 |
| Systemic disease | | | | 0.083 | Yes | 6 | 0 | 1.636 (1.261, 2.123) | | No | 22 | 14 | 1 | |
| Methods | | | | 0.094 | Iron | 16 | 5 | 1 | | Steel | 5 | 7 | 0.223 (0.049, 1.026) | 0.067 | Others | 7 | 2 | 1.094 (0.169, 7.061) | 1.000 |
| Sharp materials | | | | 0.451 | Yes | 20 | 12 | 2.400 (0.435, 13.227) | | No | 8 | 2 | 1 | |
| Injured part | | | | 0.034 | Combined | 9 | 2 | 1 | | Cornea | 14 | 4 | 0.778 (0.117, 5.162) | 1.000 | Sclera | 5 | 8 | 0.139 (0.021, 0.925) | 0.047 |
| Preoperative VA | | | | 1.000 | ≥CF | 11 | 3 | 0.797 (0.161, 3.954) | | <CF | 23 | 5 | 1 | |
| Cataract | | | | 0.321e | Yes | 22 | 9 | 2.037 (0.493, 8.408) | | No | 6 | 5 | 1 | |
| Intraocular foreign body | | | | 0.006 | Yes | 15 | 1 | 15.000 (1.721, 130.759) | | No | 13 | 13 | 1 | |
| Phase I treatment | | | | 0.107e | Yes | 18 | 5 | 3.240 (0.849, 12.360) | | No | 10 | 9 | 1 | |
| Use of silicone oil | | | | 0.826e | Yes | 15 | 8 | 0.865 (0.237, 3.153) | | No | 13 | 6 | 1 | |
| Intraocular injection | | | | 1.000 | Yes | 5 | 2 | 1.304 (0.219, 7.751) | | No | 23 | 12 | 1 | |
| Bacterial culture | | | | 0.451 | Positive | 8 | 2 | 2.400 (0.435, 13.227) | | Negative | 20 | 12 | 1 | |
| Hypopyon | | | | 0.723 | Yes | 20 | 11 | 0.682 (0.150, 3.109) | | No | 8 | 3 | 1 | |
| Time of operation | | | | 0.043 | 0–24 h | 9 | 1 | 1 | | 24–72 h | 6 | 8 | 0.083 (0.008, 0.849) | 0.033 | >72 h | 13 | 5 | 0.289 (0.029, 2.908) | 0.375 |
|
|
Abbreviations: VA, visual acuity; OR, odds ratio; 95% CI, 95% confidence interval. (a) Logistic regression analysis. (b) Fisher’s exact test. (c) Reference age has OR = 1. (d) Student t-test. (e) Chi-square analysis.
|